A multicentre Phase I clinical trial demonstrates manufacturing feasibility, safety and activity of novel humanized BCMA-directed CAR-T cell therapy.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Manju Sengar, Ashish Saroha, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Aalia Khan, Anand Vaibhaw, Rohit Beher, Shraddha Dhamale, Poonam Rathore, Supriya More, Anjali Jaiswal, Manivasagam Sundharam, Prachi Salanke, Shreewardhan Rajopadhye, Asmita Tungare, Moumita Basu, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Pranali Patil, Sushant Kumar, Girish Badarkhe, Hasmukh Jain, Rahul Purwar
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417022282
Cites:
Cited by:
Related to: